[DPHARMA] QoQ TTM Result on 31-Mar-2015 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
18-May-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
31-Mar-2015 [#1]
Profit Trend
QoQ- 1.69%
YoY- 3.21%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Revenue 271,040 232,663 197,750 182,065 176,961 171,671 167,697 37.60%
PBT 49,765 46,157 45,813 47,513 46,490 41,729 39,496 16.60%
Tax -10,980 -8,786 -8,393 -8,428 -8,009 -7,856 -7,519 28.62%
NP 38,785 37,371 37,420 39,085 38,481 33,873 31,977 13.69%
-
NP to SH 38,785 34,569 34,618 36,283 35,679 33,873 31,977 13.69%
-
Tax Rate 22.06% 19.04% 18.32% 17.74% 17.23% 18.83% 19.04% -
Total Cost 232,255 195,292 160,330 142,980 138,480 137,798 135,720 42.92%
-
Net Worth 270,323 268,530 189,815 205,045 192,951 187,531 179,145 31.45%
Dividend
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Div 5,682 25,710 25,710 25,682 25,682 24,291 24,291 -61.93%
Div Payout % 14.65% 74.38% 74.27% 70.79% 71.98% 71.71% 75.97% -
Equity
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Net Worth 270,323 268,530 189,815 205,045 192,951 187,531 179,145 31.45%
NOSH 278,959 278,959 139,570 139,486 138,813 138,912 138,872 59.00%
Ratio Analysis
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
NP Margin 14.31% 16.06% 18.92% 21.47% 21.75% 19.73% 19.07% -
ROE 14.35% 12.87% 18.24% 17.70% 18.49% 18.06% 17.85% -
Per Share
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
RPS 162.43 139.50 141.68 130.52 127.48 123.58 120.76 21.78%
EPS 23.24 20.73 24.80 26.01 25.70 24.38 23.03 0.60%
DPS 3.41 15.42 18.50 18.50 18.50 17.50 17.50 -66.28%
NAPS 1.62 1.61 1.36 1.47 1.39 1.35 1.29 16.35%
Adjusted Per Share Value based on latest NOSH - 139,486
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
RPS 28.18 24.19 20.56 18.93 18.40 17.85 17.43 37.63%
EPS 4.03 3.59 3.60 3.77 3.71 3.52 3.32 13.75%
DPS 0.59 2.67 2.67 2.67 2.67 2.53 2.53 -62.01%
NAPS 0.281 0.2792 0.1973 0.2132 0.2006 0.195 0.1862 31.46%
Price Multiplier on Financial Quarter End Date
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Date 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 -
Price 2.62 2.72 2.65 3.88 2.50 3.17 2.97 -
P/RPS 1.61 1.95 1.87 2.97 1.96 2.57 2.46 -24.56%
P/EPS 11.27 13.12 10.68 14.92 9.73 13.00 12.90 -8.58%
EY 8.87 7.62 9.36 6.70 10.28 7.69 7.75 9.38%
DY 1.30 5.67 6.98 4.77 7.40 5.52 5.89 -63.37%
P/NAPS 1.62 1.69 1.95 2.64 1.80 2.35 2.30 -20.78%
Price Multiplier on Announcement Date
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Date 23/02/16 24/11/15 25/08/15 18/05/15 24/02/15 21/11/14 26/08/14 -
Price 2.61 2.70 2.40 3.90 2.92 3.01 3.37 -
P/RPS 1.61 1.94 1.69 2.99 2.29 2.44 2.79 -30.61%
P/EPS 11.23 13.03 9.68 14.99 11.36 12.34 14.64 -16.16%
EY 8.91 7.68 10.33 6.67 8.80 8.10 6.83 19.33%
DY 1.30 5.71 7.71 4.74 6.34 5.81 5.19 -60.16%
P/NAPS 1.61 1.68 1.76 2.65 2.10 2.23 2.61 -27.47%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment